PropThink: Geron Q3 Earnings Review: Waiting Not for Godot, but for San Antonio and Atlanta

[ACN Newswire] – By Ivan DeryuginWhen a biotechnology company is around 20 years after its incorporation, common wisdom would suggest that it has become a major player in the biotechnology sector, with at least one blockbuster … more

View todays social media effects on GERN

View the latest stocks trending across Twitter. Click to view dashboard